Protara Therapeutics, Inc.
TARA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001359931
No open-market purchases or sales by Protara Therapeutics, Inc. insiders were filed in the last 90 days; 119 institutions reported holding it in 13F filings for Q2 2026, worth $176.0M in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in Protara Therapeutics, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 30
- −1 vs. Q3 2023
- Shares held
- 4.36M
- −759.8K (−14.8%) vs. Q3 2023
- Total value
- $8.17M
- −$379.2K (−4.4%) vs. Q3 2023
- New holders
- 2
- 7 more added
- Sold out
- 3
- 6 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TARA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 119 | $176.0M |
| Q1 2026 | 114 | $237.4M |
| Q4 2025 | 105 | $212.3M |
| Q3 2025 | 81 | $114.0M |
| Q2 2025 | 76 | $90.1M |
| Q1 2025 | 59 | $123.8M |
| Q4 2024 | 60 | $156.6M |
| Q3 2024 | 35 | $19.1M |
| Q2 2024 | 38 | $22.2M |
| Q1 2024 | 34 | $18.3M |
| Q4 2023 | 30 | $8.17M |
| Q3 2023 | 31 | $8.55M |
| Q2 2023 | 29 | $12.3M |
| Q1 2023 | 29 | $16.9M |
| Q4 2022 | 30 | $14.7M |
| Q3 2022 | 31 | $16.7M |
| Q2 2022 | 33 | $18.4M |
| Q1 2022 | 35 | $33.2M |
| Q4 2021 | 38 | $46.5M |
| Q3 2021 | 36 | $43.7M |
| Q2 2021 | 40 | $69.3M |
| Q1 2021 | 50 | $134.0M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Protara Therapeutics, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Qube Research & Technologies Ltd | 2 | $4 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 6 | $11 | 0.00% | +6 | New |
| JPMorgan Chase & Co | 16 | $30 | 0.00% | +5+45.5% | Added |
| Advisor Group Holdings, Inc. | 100 | $188 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 728 | $1.00K | 0.00% | +228+45.6% | Added |
| Wells Fargo & Company | 569 | $1.07K | 0.00% | +4+0.7% | Added |
| UBS Group AG | 916 | $1.72K | 0.00% | +795+657.0% | Added |
| ADAR1 Capital Management, LLC | 2,194 | $4.11K | 0.00% | +2,194 | New |
| Tower Research Capital LLC (TRC) | 4,338 | $8.13K | 0.00% | −456−9.5% | Reduced |
| Acadian Asset Management LLC | 6,314 | $11.0K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 11,506 | $21.5K | 0.00% | −6,541−36.2% | Reduced |
| LPL Financial LLC | 12,000 | $22.5K | 0.00% | +2,000+20.0% | Added |
| Assenagon Asset Management S.A. | 15,831 | $29.7K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 17,907 | $33.6K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 18,127 | $34.0K | 0.00% | −2,460−11.9% | Reduced |
| Boothbay Fund Management, LLC | 18,864 | $35.4K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 25,145 | $47.1K | 0.00% | −2,200−8.0% | Reduced |
| Two Sigma Advisers, LP | 27,018 | $50.7K | 0.00% | −800−2.9% | Reduced |
| State Street Corp | 30,900 | $57.8K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 34,316 | $64.3K | 0.00% | −286−0.8% | Reduced |
| Citadel Advisors LLC | 38,035 | $71.1K | 0.00% | +15,892+71.8% | Added |
| Bridgeway Capital Management, LLC | 64,000 | $119.7K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 78,518 | $146.9K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 113,300 | $212.0K | 0.00% | +53,200+88.5% | Added |
| Privium Fund Management (UK) Ltd | 119,730 | $224.5K | 0.15% | 00.0% | Unchanged |
| Ikarian Capital, LLC | 188,664 | $352.8K | 0.10% | 00.0% | Unchanged |
| Baker Bros. Advisors LP | 199,671 | $374.4K | 0.00% | 00.0% | Unchanged |
| Boxer Capital, LLC | 209,227 | $392.3K | 0.02% | 00.0% | Unchanged |
| Vanguard Group Inc | 427,612 | $801.8K | 0.00% | 00.0% | Unchanged |
| Opaleye Management Inc. | 2,692,594 | $5.05M | 1.36% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 0 | $0 | 0.00% | −772,584−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −34,971−100.0% | Sold out |
| Dimensional Fund Advisors LP | 0 | $0 | 0.00% | −13,821−100.0% | Sold out |